Protective effect of Shilajit against Bisphenol A-induced pulmonary histopathological alterations in male mice
DOI:
https://doi.org/10.31210/spi2026.29.02.23Keywords:
Bisphenol A, Shilajit,, pulmonary toxicity, histopathological changes, miceAbstract
Bisphenol A (BPA) is a pervasive industrial environmental pollutant widely used in chemical manufacturing, leading to continuous human and animal exposure through food and resource contamination. While its broad multi-organ toxicities are well-documented, its sub-acute destructive impact on mammalian respiratory histology requires comprehensive elucidation. Conversely, Shilajit is a traditional mineral pitch known for its potent organic constituents. This study evaluated the lung tissue alterations induced by sub-acute oral BPA exposure and investigated the potential protective efficacy of concurrent Shilajit administration in a male mouse model. Thirty healthy adult male mice were randomly assigned to three equal cohorts: vehicle control (G1), toxic exposure group receiving BPA at 400 mg/kg body weight (G2), and co-treatment group receiving BPA concurrently with Shilajit at 0.5 g/kg body weight (G3) via oral gavage for 21 consecutive days. Following euthanasia, longitudinal lung tissue samples were promptly fixed in 10 % neutral buffered formalin for 48 hours, embedded in paraffin blocks, sectioned, and stained with hematoxylin and eosin (H&E). Stained specimens were subjected to qualitative screening and quantitative scoring. Data were statistically evaluated using Kruskal-Wallis, Dunn’s post hoc, and Fisher’s exact tests. Microscopic evaluation revealed extensive, severe structural damage in 90 % of the BPA-alone group (G2), characterized by diffuse interalveolar septal thickening driven by heavy mononuclear cell (MNC) infiltration, dense accumulation of amorphous proteinaceous exudates within the respiratory spaces, perivascular leukocytic aggregation, and focal alveolar wall rupture driving emphysematous alterations. Conversely, concurrent Shilajit administration (G3) significantly mitigated these changes (P<0.05), successfully restoring normal lung histoarchitecture in 70 % of the cohort. The protected parenchyma demonstrated well-preserved alveolar matrices with mild congestion and localized, contained MNC infiltration. Notably, the G3 group uniquely exhibited distinct interstitial granulomatous accumulations and spherical micro-cavities within the microvascular beds, indicating active tissue regeneration.
References
1. Manzoor, M. F., Tariq, T., Fatima, B., Sahar, A., Tariq, F., Munir, S., Khan, S., Ranjha, M. M. A. N., Sameen, A., Zeng, X.-A., & Ibrahim, S. A. (2022). An insight into bisphenol A, food exposure and its adverse effects on health: A review. Frontiers in Nutrition, 9, 1047827. https://doi.org/10.3389/fnut.2022.1047827
2. European Chemicals Agency (ECHA). (2015). Member State Committee support document for identification of bisphenol A as a substance of very high concern due to its endocrine disrupting properties. European Chemicals Agency.
3. Eid, J. I., Eissa, S. M., & El-Ghor, A. A. (2015). Bisphenol A induces oxidative stress and DNA damage in hepatic tissue of female rat offspring. The Journal of Basic and Applied Zoology, 71, 10–19. https://doi.org/10.1016/j.jobaz.2015.01.006
4. Alshahrani, S., Al-Botaty, B., El Morsy, E., & Nofal, S. (2026). Toxicological effects and mechanisms of Bisphenol A exposure: Article review. Journal of Advanced Pharmacy Research, 10(1), 54–69. https://doi.org/10.21608/aprh.2025.414957.1337
5. National Toxicology Program. (2008). Toxicology and carcinogenesis studies of bisphenol A (CAS No. 80-05-7) in F344/N rats and B6C3F1 mice (feed studies) (NTP TR 545). U.S. Department of Health and Human Services.
6. Faheem, N. M., EL Askary, A., & Gharib, A. F. (2021). Lycopene attenuates bisphenol A–induced lung injury in adult albino rats: A histological and biochemical study. Environmental Science and Pollution Research, 28(35), 49139–49152. https://doi.org/10.1007/s11356-021-14140-w
7. Shi, Y., Chen, W., Du, Y., Zhao, L., & Li, Q. (2023). Damage effects of bisphenol A against sepsis induced acute lung injury. Gene, 878, 147575. https://doi.org/10.1016/j.gene.2023.147575
8. Krishnan, A. V., Stathis, P., Permuth, S. F., Tokes, L., & Feldman, D. (1993). Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology, 132(6), 2279–2286. https://doi.org/10.1210/endo.132.6.8504731
9. Gayrard, V., Viguie, C., Cabaton, N., Person, E., Zalko, D., Grandin, F., Berrebi, A., Metsu, D., Toutain, P.-L., & Picard-Hagen, N. (2023). Importance of relative binding of bisphenol A and bisphenol S to plasma proteins for predicting their in vivo potencies. Toxicology and Applied Pharmacology, 466, 116477. https://doi.org/10.1016/j.taap.2023.116477
10. Shin, B. S., Kim, C. H., Jun, Y. S., Kim, D. H., Lee, B. M., Yoon, C. H., Park, E. H., Lee, K. C., Han, S.-Y., Park, K. L., Kim, H. S., & Yoo, S. D. (2004). Physiologically based pharmacokinetics of bisphenol A. Journal of Toxicology and Environmental Health, Part A, 67(23-24), 1971–1985. https://doi.org/10.1080/15287390490514615
11. Qadir, A., Rehman, S. A., Khan, N., Bedi, B. D. S., Ali, A., & Iqubal, A. (2025). Beyond fulvic acid: A mini-review of the diverse chemical constituents of shilajit. International Journal of Ayurvedic and Herbal Medicine, 15(5), 5150–5159.
12. World Health Organization. (2013). WHO traditional medicine strategy: 2014–2023. World Health Organization.
13. Stohs, S. J. (2013). Safety and efficacy of Shilajit (Mumie, Moomiyo). Phytotherapy Research, 28(4), 475–479. https://doi.org/10.1002/ptr.5018
14. Suvarna, S. K., Layton, C., & Bancroft, J. D. (Eds.). (2019). Bancroft's theory and practice of histological techniques (8th ed.). Elsevier.
15. Yanagisawa, R., Koike, E., Win-Shwe, T.-T., & Takano, H. (2019). Oral exposure to low dose bisphenol A aggravates allergic airway inflammation in mice. Toxicology Reports, 6, 1253–1262. https://doi.org/10.1016/j.toxrep.2019.11.012
16. National Institute for Public Health and the Environment (RIVM). (2014). Bisphenol A. Part 1. Facts and figures on human and environmental health issues and regulatory perspectives (RIVM Report No. 601351001). Ministry of Health, Welfare and Sport. https://www.rivm.nl/bibliotheek/rapporten/601351001.html
17. Meena, H., Pandey, H. K., Arya, M. C., & Ahmed, Z. (2010). Shilajit: A panacea for high-altitude problems. International Journal of Ayurveda Research, 1(1), 37–40. https://doi.org/10.4103/0974-7788.59942
18. Velmurugan, C., Vivek, B., Wilson, E., Bharathi, T., & Sundaram, T. (2012). Evaluation of safety profile of black shilajit after 91 days repeated administration in rats. Asian Pacific Journal of Tropical Biomedicine, 2(3), 210–214. https://doi.org/10.1016/s2221-1691(12)60043-4
19. Bhattacharya, S. K., Sen, A. P., & Ghosal, S. (1995). Effects of shilajit on biogenic free radicals. Phytotherapy Research, 9(1), 56–59. https://doi.org/10.1002/ptr.2650090113
20. Zykova, M. V., Trofimova, E. S., Azarkina, L. A., Lasukova, T. V., Mihalyov, D. A., Drygunova, L. A., Danilets, M. G., Ligacheva, A. A., Tsupko, A. V., Bashirov, S. R., & Belousov, M. V. (2025). Pharmacological effects of humic substances and their signaling mechanisms. Molecules, 31(1), 114. https://doi.org/10.3390/molecules31010114
21. Winkler, J., & Ghosh, S. (2018). Therapeutic potential of fulvic acid in chronic inflammatory diseases and diabetes. Journal of Diabetes Research, 2018, 1–7. https://doi.org/10.1155/2018/5391014
